Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucin apoprotein expression in COPD.

George D Leikauf1, Michael T Borchers, Daniel R Prows

  • 1Molecular Toxicology Division, Department of Environmental Health, University of Cincinnati, Cincinnati, OH 45267-0056, USA. leikaugd@uc.edu

Chest
|May 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

VEGF-D Dependent IFNγ Production by Natural Killer Cells in Lymphangioleiomyomatosis.

Journal of cellular immunology·2026
Same author

Soluble Major Histocompatibility Complex I-Related Chain A (sMICA)*008 Levels Associate with Smoking, Presence of Chronic Obstructive Pulmonary Disease, and Prevalence of Lung Cancer.

Journal of clinical medicine·2026
Same author

Inflammatory, Functional, and Compositional Changes of the Uterine Immune Microenvironment in a Lymphangioleiomyomatosis Mouse Model.

Journal of cellular immunology·2025
Same author

Anti-CELA1 antibody KF4 prevents emphysema by inhibiting stretch-mediated remodeling.

JCI insight·2024
Same author

Chymotrypsin-like Elastase-1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2023
Same author

Associations of Smoking, Cytomegalovirus Serostatus, and Natural Killer Cell Phenotypes in Smokers With and At Risk for COPD.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2023

Mucins are key glycoproteins for airway protection. Their regulation in COPD is poorly understood, but MUC5AC and MUC5B show distinct expression patterns, offering potential therapeutic targets.

Area of Science:

  • * Biochemistry and Molecular Biology: Focuses on the structure, function, and genetic regulation of mucins, complex glycoproteins vital for airway health.
  • * Genomics and Proteomics: Investigates mucin gene families, their chromosomal locations, and protein variations through post-translational modifications.
  • * Respiratory Medicine: Explores the role of mucins in airway diseases like COPD and potential therapeutic strategies.

Background:

  • * Mucins are essential glycoproteins providing viscoelastic properties to mucus, crucial for airway protection.
  • * They are characterized by variable-number tandem repeats (VNTRs) and can undergo alternative splicing and post-translational modifications like glycosylation.
  • * Fifteen distinct mucin genes exist, categorized into membrane-associated and secreted types, with several localized to the lung.

Purpose of the Study:

  • * To elucidate the current understanding of mucin regulation in Chronic Obstructive Pulmonary Disease (COPD).

Related Experiment Videos

  • * To explore the genetic determinants influencing mucus hypersecretion.
  • * To identify potential clinical targets and therapeutic strategies based on mucin biology.

    • Main Methods:

    • * Review of existing literature on mucin structure, function, and genetics.
    • * Analysis of recent studies investigating mucin expression in response to environmental factors like acrolein and cigarette smoke.
    • * Examination of preliminary findings from animal models regarding genetic control of mucin formation.

    Main Results:

    • * MUC5AC is inducible by acrolein and cigarette smoke, linked to EGF pathways, while MUC5B is constitutively expressed and increases with gland enlargement in COPD.
    • * Genetic analysis in animal models suggests that differences in acrolein-induced mucin formation are genetically influenced.
    • * Limited knowledge exists regarding mucin regulation and genetic determinants in COPD patients.

    Conclusions:

    • * Mucin expression patterns (MUC5AC and MUC5B) in response to stimuli like cigarette smoke offer insights into COPD pathogenesis.
    • * Understanding the functional genomics of mucins is crucial for developing novel therapeutic strategies for mucus hypersecretion.
    • * Further research into mucin regulation and genetic factors in COPD is warranted to identify new clinical targets.